The FDA cited language suggesting MEDVi was the compounder of these drugs and claims the agency stated implied FDA approval or evaluation of compounded products
Chicago Chaphalkar, Sushama R
Program Operations and Oversight Due to financial limitations, the program requires stringent management
The two most studied pathways are: G-Protein Signaling: The canonical pathway where the receptor activates a G-protein (like Gs for GIPR and GLP-1R), which in turn modulates the activity of an effector enzyme like adenylyl cyclase to produce cAMP
I mean, if this things too big, you cant fit a gigantic molecule through a very small hole
Additionally, these medications influence gut motility more broadly, potentially altering intestinal transit time